Seven & i Holdings (3382) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
13 Nov, 2025Executive summary
Operating income for the first half of FY2025 was JPY 208.3 billion, up 11.4% year-on-year and 5.8% above plan, driven by strong domestic and overseas CVS performance.
Net income attributable to owners of parent surged 133.1% year-on-year to JPY 121.8 billion, mainly due to reduced extraordinary losses and gains from asset sales.
Revenues from operations declined 6.9% year-on-year to JPY 5,616.6 billion, primarily due to lower retail fuel prices overseas.
Strategic transformation programs, including cost discipline, product innovation, and digital initiatives, are underway and delivering results.
Major divestitures of Seven Bank and superstore businesses were completed, focusing the group on global convenience store operations.
Financial highlights
EBITDA for the first half was JPY 485.4 billion, up from JPY 471.5 billion year-on-year.
EPS before goodwill amortization rose to JPY 68.76, up from JPY 38.87 year-on-year.
Special losses dropped significantly to JPY 31.2 billion from JPY 86.2 billion in the prior year.
Comprehensive income was a loss of JPY 123.8 billion, mainly due to foreign currency translation adjustments.
Goodwill amortization was JPY 69.2 billion.
Outlook and guidance
Full-year net income forecast was raised to JPY 265.0 billion, while operating income and revenue forecasts were revised downward.
EPS for FY2025 is projected at JPY 107.66, with run-rate EPS expected to reach JPY 159.37 due to share buybacks.
Annual dividend forecast set at JPY 50.0 per share, up from JPY 40.0 in the prior year.
Guidance revisions reflect expected gains from business divestitures and ongoing transformation programs.
Latest events from Seven & i Holdings
- Revenue up, profits down as acquisitions and inflation reshape global strategy.3382
Q1 20253 Feb 2026 - Profits and EPS soared on special gains and buybacks, with full-year outlook raised.3382
Q3 20262 Feb 2026 - Revenue up, profit down as restructuring and overseas expansion reshape the business.3382
Q2 202519 Jan 2026 - Revenue up, profit down sharply; reforms and overseas expansion set stage for 2025 growth.3382
Q3 202510 Jan 2026 - Net income set to surge as reforms, buybacks, and SEI IPO drive future growth.3382
Q4 202520 Dec 2025 - Aggressive global expansion, digital innovation, and capital discipline drive 2030 growth targets.3382
Investor Day 202517 Dec 2025 - Net income surged 229% YoY on asset sales, with portfolio reforms and guidance maintained.3382
Q1 20267 Nov 2025